EBR Systems Expands Patent Portfolio with New Grants

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has issued an announcement.

EBR Systems, Inc. has announced the expansion of its intellectual property portfolio with the granting of four new patents, three from the US Patent and Trademark Office and one from the Japan Patent Office. This development enhances the protection of its WiSE technology, the world’s only wireless cardiac pacing device for heart failure, and extends the patent runway for its innovations. However, the company has received a preliminary disallowance notice from the USPTO regarding a patent term extension application, which it is currently addressing. The continued growth of EBR’s patent portfolio underscores its commitment to research and development, potentially strengthening its market position and creating barriers for competitors.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

Silicon Valley-based EBR Systems, Inc. is a company focused on the treatment of cardiac rhythm diseases through its proprietary Wireless Stimulation Endocardially (WiSE) technology. This technology aims to provide more effective cardiac pacing by eliminating the need for traditional leads, which are often associated with complications. EBR’s initial product targets heart failure patients requiring Cardiac Resynchronisation Therapy (CRT), with future potential applications for bradycardia and other non-cardiac indications.

Average Trading Volume: 695,156

Technical Sentiment Signal: Sell

Current Market Cap: A$416.2M

For detailed information about EBR stock, go to TipRanks’ Stock Analysis page.